Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Immuneering Corp Cl A (IMRX)

Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates GlobeNewswire - Wed Nov 13, 3:05PM CST

IMRX : 2.15 (+5.39%)
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer GlobeNewswire - Tue Oct 15, 7:00AM CDT

IMRX : 2.15 (+5.39%)
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% BayStreet.ca - Fri Oct 4, 8:19AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Although death rates for some cancers are declining, the world is facing a sharp increase in cancer...

ONCY : 0.9850 (-1.35%)
ZNTL : 3.14 (+0.32%)
TIL : 24.41 (+4.49%)
IMRX : 2.15 (+5.39%)
ZLAB : 25.76 (-1.79%)
ONC.TO : 1.40 (unch)
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments BayStreet.ca - Fri May 17, 10:48AM CDT

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 0.9850 (-1.35%)
ONC.TO : 1.40 (unch)
RHHBY : 35.3700 (+0.68%)
MRUS : 44.52 (+3.70%)
MGNX : 3.28 (+0.15%)
IMRX : 2.15 (+5.39%)
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth FinancialNewsMedia - Wed Mar 6, 7:40AM CST

EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END

ONCY : 0.9850 (-1.35%)
ONC.TO : 1.40 (unch)
BLRX : 0.3375 (-38.10%)
IMRX : 2.15 (+5.39%)
CADL : 4.22 (+6.03%)
Why Shares of Immuneering Jumped This Week Motley Fool - Fri Mar 24, 2023

Immuneering is ready to share information regarding its lead therapy.

IMRX : 2.15 (+5.39%)
Pyramid Biosciences Names Biren Amin as Chief Financial and Strategy Officer Business Wire - Wed Sep 7, 2022

Pyramid Biosciences, Inc., a Boston-based, clinical-stage, biotechnology company focused on developing new and highly differentiated precision therapies for cancer, today announced the expansion of its...

IMRX : 2.15 (+5.39%)
Immuneering Announces Participation in William Blair Biotech Focus Conference 2022 Globe Newswire - Wed Jul 6, 2022

CAMBRIDGE, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational...

IMRX : 2.15 (+5.39%)
Immuneering Reports Data in Two Preclinical Abstracts at the ASCO 2022 Annual Meeting Highlighting Pan-KRAS/NRAS Activity of IMM-1-104 Globe Newswire - Thu May 26, 2022

IMM-1-104 strongly inhibits tumor growth in an animal model of KRAS-G12V mutant pancreatic cancer Preclinical data package now includes animal studies...

IMRX : 2.15 (+5.39%)
Immuneering Announces Participation in Upcoming Investor Conferences Globe Newswire - Fri May 20, 2022

CAMBRIDGE, Mass., May 20, 2022 (GLOBE NEWSWIRE) --  Immuneering Corporation (NASDAQ: IMRX), a biopharmaceutical company using translational...

IMRX : 2.15 (+5.39%)

Barchart Exclusives

1 EV Stock Under $10 With 25% Upside Potential Barchart - 1 hour ago
This charging stock has been under heavy pressure lately amid concerns over the fate of EV tax credits. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot